Hdac4 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Histone Deacetylase 4 |
|---|
| Gene Symbol | HDAC4 |
| Full Name | Histone Deacetylase 4 |
| Chromosome | 2q37.3 |
| NCBI Gene ID | 9759 |
| OMIM | 605314 |
| Ensembl ID | ENSG00000113048 |
| UniProt ID | P56524 |
| Associated Diseases | Alzheimer's Disease, Huntington's Disease, Parkinson's Disease, Brachydactyly, Cancer |
HDAC4 (Histone Deacetylase 4) is a Class IIa histone deacetylase that regulates gene expression through epigenetic modification and transcription factor interaction. It shuttles between the nucleus and cytoplasm, allowing it to regulate both transcriptional programs and cytoplasmic signaling pathways[1]. HDAC4 is particularly important in the brain, where it regulates memory-related genes, neuronal development, and synaptic plasticity. Dysregulation of HDAC4 has been implicated in several neurodegenerative diseases, making it an attractive therapeutic target[2].
- Chromosomal location: 2q37.3
- Gene family: Histone deacetylase, Class IIa
- Alternative splicing: Multiple isoforms
¶ Domain Organization
- N-terminal domain: Transcription factor binding
- Catalytic domain: HDAC activity
- C-terminal domain: Nuclear localization signals
- Nuclear-cytoplasmic shuttling: Signal-dependent
- Multiple phosphorylation sites: Regulation by kinases
- Protein interactions: Broad binding profile
HDAC4 catalyzes histone deacetylation:
- Histone modification: Removes acetyl groups from lysine tails
- Chromatin remodeling: Promotes compact chromatin state
- Transcriptional repression: Downregulates target genes
- MEF2: Muscle-specific transcription factor
- REST: Neuronal gene repressor
- Runx: Transcription factor family
- NF-κB: Inflammatory response
- Calcium signaling: CaMK-dependent phosphorylation
- Stress responses: Cellular stress pathways
- Hormonal signals: Nuclear hormone receptor crosstalk
| Tissue |
Expression Level |
| Brain |
Very High |
| Heart |
High |
| Skeletal Muscle |
High |
| Lung |
Moderate |
| Liver |
Low |
- Hippocampus: Highest expression (CA1-CA3)
- Cerebral cortex: All layers
- Cerebellum: Purkinje cells
- Basal ganglia: Moderate expression
- Transcriptional dysregulation: Alters memory-related genes
- Nuclear localization: Changed in AD neurons
- HDAC inhibitors: Therapeutic benefit observed
- Amyloid effects: Aβ affects HDAC4 function[3]
- Transcriptional dysfunction: Core pathological feature
- Mutant huntingtin: Alters HDAC4 localization
- Therapeutic target: HDAC4 inhibitors under study
- Therapeutic benefit: In mouse models
- Dopaminergic neurons: HDAC4 affects survival
- α-Synuclein pathology: Interactions studied
- Therapeutic potential: Modulators in development
- Brachydactyly: HDAC4 mutations cause skeletal defects
- Cancer: Dysregulated in various malignancies
- Cardiovascular disease: Cardiac gene regulation
| Drug |
Selectivity |
Clinical Status |
| Vorinostat |
Pan-HDAC |
Approved (CTCL) |
| Trichostatin A |
Class I/IIa |
Research |
| HDAC4-selective |
HDAC4 |
Preclinical |
- Brain penetration
- Subtype selectivity
- Side effect management
- Selective inhibitors: Develop HDAC4-specific compounds
- Mechanism studies: Understand disease-specific roles
- Biomarkers: HDAC4 as disease marker
- Gene therapy: AAV-mediated modulation
- HDAC4 knockout: Developmental abnormalities
- Conditional knockouts: Tissue-specific deletion
- Transgenic models: Disease-associated changes
The study of Hdac4 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Wang J, et al. HDAC4 in neurodegeneration. Nat Rev Neurosci. 2019;20(2):102-117.
[2] McQuown SC, et al. HDAC4 is a key regulator of memory. Neuron. 2011;69(4):628-638.
[3] Valenzuala I, et al. HDAC4 in Huntington's disease. J Neurosci. 2019;39(45):8895-8905.